Letter

Travel prophylaxis

BMJ 1995; 310 doi: 10.1136/bmj.310.6978.533a (Published 25 February 1995)
Cite this as: BMJ 1995;310:533.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R H Behrens,
  2. J A Roberts
  1. Consultant physician in tropical and travel medicine Hospital for Tropical Diseases Travel Clinic, London NW1 0PE
  2. Senior lecturer Health Services Research Unit, London School of Hygiene and Tropical Medicine, London WC1T 7HT

    EDITOR,—Pierre van Damme and colleagues and E Walker support the findings of our study that high risk travellers should be selectively immunised, but they disagree about other issues. The aim of our study was to provide a framework in which policy related to travel prophylaxis could be explored in the context of the NHS.1

    While acknowledging that underreporting occurs, we used a correction factor of 50%. This factor includes adjustment for diseases with short incubation periods, such as malaria and typhoid, which may well present …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular